Obesity Management Market


Obesity Management Market: Global Industry Analysis

and Opportunity Assessment 2017-2027

May 2017

Report Id : REP-GB-587

Status : April-2017

Category : Healthcare, Pharmaceuticals & Medical Devices

©2015 Future Market Insights, All Rights Reserved


Future Market Insights

Future Market Insights (FMI) is a premier provider of syndicated research reports, custom

research reports, and consulting services. We deliver a complete packaged solution, which

combines current market intelligence, statistical anecdotes, technology inputs, valuable growth

insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC,


Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,

Technology, Healthcare, and Retail.

We have a global presence with delivery centers across India specializing in providing global

research reports and country research reports. FMI is headquartered out of London, U.K., with a

state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning

from every corner of the world to distill it to one thing – the perfect solution for our client.

Research Capabilities

Sector Coverage

Customized Research

Syndicated Research

Investment Research

Social Media Research

Automotive and Transportation

Electronics, Semiconductor, and ICT

Retail and Consumer Products

Industrial Automation and Equipment

Chemicals & Materials

Food and Beverages

Services and Utilities

Energy, Mining, Oil, and Gas







Social Media


Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Email: hari.t@futuremarketinsights.com

©2015 Future Market Insights, All Rights Reserved


Research Methodology (1/2)

Systematic Research Approach

Market profiling

Formulating discussion guide

Developing list of respondents

Data collection

Data validation






In-depth secondary research is used to

ascertain overall market size, top

industry players, top products, industry

associations, etc.

PMR formulates a detailed discussion

guide to conduct expert and industry


PMR develops a list of industry players

(manufacturers), distributors, retailers

and industry experts

PMR conducts interviews with industry

experts, industry players, distributors

and retailers

Data is validated by triangulation

method, wherein secondary, primary

and PMR analysis contribute to the final




Data Filter

& Analysis

Identifying key opinion leaders

Questionnaire design

In-depth interviews

Coverage across value chain

Market participants

Key strengths

Product portfolio

Mapping as per value chain

Key focus segments







Research &










Key industry experts

Channel study


Market dynamics



Data analysis


Data is scrutinized using MS-Excel to

obtain qualitative and quantitative

insights about the industry

Primary Research #

Secondary Research #

Paid Publications#



PMR delivers industry insights and

information in the required format






Company websites

Company annual


White papers

Financial reports





# includes sources of databases

©2015 Future Market Insights, All Rights Reserved


Obesity Management Market

High costs involved in the research & development (R&D) of obesity drugs, coupled with limited financial

support, are collectively a great challenge for adoption of obesity management solutions. Additionally, long

gestation time needed for R&D activities, and the inclusion of clinical trials required to test these drugs hikes

the expenditure significantly. Considering this scenario, manufacturers are being cautious while seeking

better return on investments. In the long run, risks and limitations posed by the high development costs of

obesity drugs are likely to impede the growth of the global obesity management market.

Future Market Insights’ latest publication estimates that the global market for obesity management will

showcase an average growth during the forecast period, 2017-2027. In this period, the market is estimated

to grow from US$ 641.6 Mn in 2016 to US$ 1,078.9 by 2027-end, representing a value CAGR of 4.9%.

Between 2017 and 2027, the global obesity management market is poised to witness an incremental $

opportunity of over US$ 400 Mn.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-587

In addition the high costs for developing obesity management drugs, the market is also expected to witness

restraints from poor healthcare infrastructure in emerging markets. Stringent laws imposed upon drug

manufacturers are also impacting the market’s growth. These laws are becoming more ambiguous, resulting

into a slow-down in drug production. Moreover, studies revealing side effects of obesity management drugs

are also causing major disturbance among regulatory bodies and manufacturers. GlaxoSmithKline plc.,

VIVUS, Inc., Novo Nordisk A/S, Arena Pharmaceuticals, Inc., F. Hoffmann La Roche Ltd., and Orexigen,

Therapeutics, Inc. are companies profiled in the report as leading participants of global obesity management


©2015 Future Market Insights, All Rights Reserved 4

Obesity Management Market

A regional analysis of global obesity management market, compiled in the report, projects that North

America’s share on global revenues will surpass 33% towards the end of 2027. North America is anticipated

to emerge as the largest market for obesity management in the world. Western Europe will also be at the

forefront, bringing in an estimated US$ 222 Mn in revenues by 2027-end. Across different regions in the

world, a majority of obesity management drugs will be distributed through hospital pharmacies. With more

than 50% share in global revenues, hospital pharmacies will remain the largest distribution channel for

obesity management drugs throughout the forecast period.

Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-587

In terms of surgery, the global demand for obesity management drugs is primarily concentrated towards

treatments namely, gastric bypass surgery and gastric sleeve surgery. In addition to this, the report also

projects that over one-third of global obesity management revenues will be accounted by global sales of

liraglutide drugs. Demand for phentermine and topiramate drugs will also gain traction, registering revenue

growth at 7% CAGR. Nonetheless, fastest revenue growth will be recorded by global sales of bupropion and

naltrexone drugs, revenues from which will surpass US$ 100 Mn by end of 2027.

Browse Full Report@ http://www.futuremarketinsights.com/reports/obesity-management-market

Click here to

Order a free sample

©2015 Future Market Insights, All Rights Reserved 5

Table of Content

1. Executive Summary

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3. Global Obesity Management Market Analysis Scenario

3.1. Market Size (US$ Mn) and Forecast

3.1.1. Market Size and Y-o-Y Growth

3.1.2. Absolute $ Opportunity

3.2. Market Overview

4. Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply and Demand Side

4.3. Restraints

4.4. Opportunity

4.5. Forecast Factors – Relevance and Impact

4.6.Scenario Forecast


4.8.Regulations Scenario

4.9.Drug Pipeline Assessment

4.10.Epidemiology Analysis

©2015 Future Market Insights, All Rights Reserved


Table of Content

5. Global Obesity Management Market Analysis and Forecasts, By Drug Type

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Drug Type

5.3. Y-o-Y Growth Projections By Drug Type

5.4. Market Value Forecast By Drug Type, 2017–2027

5.4.1. Bupropion and Naltrexone

5.4.2. Orlistat

5.4.3. Lorcaserin

5.4.4. Phentermine and Topiramate

5.4.5. Liraglutide

5.5. Market Attractiveness By Drug Type

6. Global Obesity Management Market Analysis and Forecasts, By Surgery Type

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By Surgery Type

6.3. Y-o-Y Growth Projections By Surgery Type

6.4. Market Value Forecast By Surgery Type, 2017–2027

6.4.1. Gastric Bypass Surgery

6.4.2. Adjustable Gastric Banding Surgery

6.4.3. Gastric Sleeve Surgery

6.4.4. Duodenal Switch Surgery

6.4.5. Others

©2015 Future Market Insights, All Rights Reserved


Table of Content

7. Global Obesity Management Market Analysis and Forecasts, By Distribution Channel

7.1. Introduction

7.2. Basis Point Share (BPS) Analysis By Distribution Channel

7.3. Y-o-Y Growth Projections By Distribution Channel

7.4. Market Value Forecast By Distribution Channel, 2017–2027

7.4.1. Hospitals Pharmacies

7.4.2. Retail Pharmacies

7.4.3. E- Commerce

7.5. Market Attractiveness By Distribution Channel

8. Global Obesity Management Market Analysis and Forecasts, By Region

8.1. Basis Point Share (BPS) Analysis By Region

8.2. Y-o-Y Growth Projections By Region

8.3. Market Value Forecast By Region

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. APEJ

8.3.6. Japan

8.3.7. MEA

8.4. Market Attractiveness By Region

Click here to

Order a free sample

©2015 Future Market Insights, All Rights Reserved


To know more about us, please visit our website:


For sales queries or new topics email us on:


For media queries, contact the press office at


For other queries contact:

Hari. T (Sr. Manager - Global Business Development)

Future Market Insights: 3rd Floor,

207 Regent Street, London W1B 3HH

T: +44 20 7692 8790 | D: +44 20 3287 4268

Email: hari.t@futuremarketinsights.com

Thank You

Future Market Insights Global & Consulting Private Limited (FMI)

©2015 Future Market Insights, All Rights Reserved


More magazines by this user
Similar magazines